Search for a pharmaceutical for marijuana dependency;Búsqueda de un tratamiento farmacológico para la dependencia de la marihuana

Adicciones

Volumn 18, Issue 1, 2006, Pages 5-10

  Ramos Atance, José Antonio ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Anandamide; Endocannabinoid systems; Marijuana; Rimonabant; Uptake inhibitors; 9 tetrahydrocannabinol

Indexed keywords

ANANDAMIDE; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; DRONABINOL; ENDOCANNABINOID;

CANNABIS ADDICTION; DRUG HALF LIFE; HUMAN; REVIEW; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE; WITHDRAWAL SYNDROME;

EID: 33646375411     PISSN: 02144840     EISSN: None     Source Type: Journal    
DOI: 10.20882/adicciones.351     Document Type: Review

References (18)

1. Budney, A., Moore, B., Vandrey, R., y Hughes, J. (2003). The time course and significance of cannabis withdrawal. J. Abnorm. Psychol, 112, 393-402.
2. Cornelius, J.R., Salloum, J.M., Haskett, R.F., Ehler, J.G., Jarrett, P.J. Thase, M.E. y Perel, J.M. (1998). Fluoxetine versus placebo for the marihuana use of depressed alcoholics. Addictive Behaviors, 24, 111-114.
3. Di Marzo, V., Berrendero, F., Bisogno, T., Gonzalez, S., Cavaliere, R, Romero, J., Cebeira, M., Ramos, J.A. y Fernandez-Ruiz, J. (2000). Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of δ-9-tetrahydrocannabinol-tolerant rats. J. Neurochem, 74, 1627-35.
4. Fegley, D., Kathuria, S., Mercier, R., Li, C., Makriyannis, A. y Piomelli D. (2004). Anandamide transport is independent of fatty acid amide hydrolase activity and is blocked by the hydrolisis resistant inhibitor AM1172. Proc. Natl. Acad. Sci. USA, 99, 8756-61.
5. Gaetani, S., Cuomo, V. y Piomelli D. (2003). Anandamide hydrolisis: a new target for anti-anxiety drugs? Trends Mol. Medicine, 9, 474-8.
6. González, S., Fernandez-Ruiz, J., di Marzo, V., Hernandez, M.L., Arevalo, C., Nicanor, C., Cascio, MG., Ambrosio, E. y Ramos, J.A. (2004). Behavioural and molecular changes elicited by acute administration of SR141716 to δ-9-tetrahidrocannabinol-tolerant rats; an experimental model of cannabinoid abstinence. Drug and Alcohol Depend, 74, 159-770.
7. Haney, M., Ward, A.S., Comer, S.D., Hart. C.L., Foltin, R.W. y Fischman, M.W. (2001). Bupropion SR worsens mood during marihuana withdrawal in humans: Psychopharmacology, 155, 171-79.
8. Haney, M., Hart, C., Ward, A.S. y Foltin, R.W. (2003). Nefadone decreases anxiety during marihuana withdrawal in humans. Psychopharmacology, 165, 157-65.
9. Haney, M., Hart, C., Vosburg, S., Nasser, J., Bennett, A., Zubaran, C. y Foltin, R.W. (2004). Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology, 29, 158-70.
10. Hart, C.L., Haney, M., Ward, A.S., Fischman, M.W. y Foltin, M.W. (2002). Effects of oral THC maintenance on smoked marijuana self-administration. Drug Alcohol Depend, 67,301-9.
11. Leza, J.C. Opiáceos (III) (2003). Tratamiento de la dependencia opiácea (I). Agonistas opiáceos. En P. Lorenzo, JM Ladero, Leza JC Lizasoain I (Eds.), Drogodependencias: Farmacología. Patología. Psicología. Legislación. (pp 115-125) Editorial Medica Panamericana. Madrid.
12. López-Rodriguez, M.L., Viso, A., Ortega-Gutierrez, S., Fowler, Ch., Tiger, G., De Lago, E., Fernandez-Ruiz, J. y Ramos, J.A. (2003). Design, synthesis and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase. J. Med. Chem, 46, 1512-22.
13. Maldonado, R. (2002). Study of cannabinoid dependence in animals. Pharmacol Ther, 95, 153-64.
14. McRae, A.L., Sonne, S.C. y Brady, K.T. (2000). The use of buspirone for the treatment of persistent anxiety in methadone-maintained patients. Paper presented at the College on Problems of Drug Dependence 62 Annual Scientific meeting San Juan, Puerto Rico.
15. McRae, A.L., Budney, A.J. y Brady KT (2003). Treatment of marihuana dependence: a review of the literature. J. Substance Abuse Treatment, 24, 369-376.
16. Morakinyo, O. (1983). Aversión therapy of cannabis dependence. Drug Alcohol Depend, 12, 287-293.
17. SantoDomingo, J. y Jimenez Arriero M.A. (Coordinadores). (2003). Capitulo IV Cannabis, en Consenso de la Sociedad Española de Psiquiatría sobre el diagnóstico y tratamiento del alcoholismo y otras adicciones. (Pp. 85-91). Sociedad Española de Psiquiatria.
18. Solé, J. (2001). Consideraciones Terapéuticas, en Cannabinoides: Aspectos Psiquiátricos y Bioquímicos. Solé, J. y Ramos, J.A, (Eds.), (pp.75-92). Barcelona, Ediciones Rol S.A.